Published 3 days ago • loading... • Updated 3 days ago

BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at William Blair

William Blair began coverage on shares of BridgeBio Pharma in a research report on Tuesday. They issued an "outperform" rating on the stock.

William Blair began coverage on shares of BridgeBio Pharma in a research report on Tuesday. They issued an "outperform" rating on the stock.

3 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated3 days agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in 3 days ago on Tuesday, March 10, 2026.

Sources are mostly out of (0)